Panorama Medical

Panorama Medical Imaging is a professional medical institution dedicated to the diagnosis of difficult diseases. As a pioneer in precision imaging, a practitioner of in-depth health screening, and a provider of exclusive medical services, Panorama relies on precision imaging diagnosis as its main technical support, adheres to the development philosophy of "establishing professionalism and leading by academia," and implements a strict quality control system to provide the public with imaging diagnosis, in-depth health screening, and exclusive medical services. Panorama has more than 600 full-time professionals of various specialties, including over 80 senior titles such as doctoral supervisors, professors, chief physicians, and deputy chief physicians, including winners of the National Science and Technology Achievement Second Prize and provincial/municipal Science and Technology Progress First Prize. It is equipped with the world's cutting-edge "multimodal" imaging screening equipment - PET/MR, as well as a series of imaging diagnostic equipment from Siemens, GE, and Philips, such as PET/CT, dual-source spiral CT, and MR (magnetic resonance), which can screen for various benign and malignant tumors, cardiovascular and cerebrovascular diseases, and neurological diseases throughout the body. As a leader in the third-party independent medical imaging diagnosis industry, Panorama innovatively proposes the concept of "integration," that is, integrating clinical and imaging, and conducting clinical needs-based imaging examinations through "consulting clinical departments." To date, it has formed a comprehensive imaging examination system, covering a complete set of plans from imaging scanning processes to expert diagnosis and quality monitoring, assisting clinical diagnosis and treatment services. It collaborates with local hospitals for extensive exchanges and cooperation, focusing on the screening and diagnosis of tumors and cardiovascular and cerebrovascular diseases, such as the assessment of carotid plaque vulnerability. Driven by the development philosophy of "establishing professionalism and leading by academia," Panorama has placed great emphasis on scientific research since its inception, collaborating with clinical departments on a series of research projects, including moyamoya disease, epileptic focus localization, brain PET/MR quantitative image analysis, liver fat quantitative analysis, and articular cartilage lesions. It actively participates in research topics and patent applications of local science and technology commissions and health commissions. In 2020, it obtained a national invention patent for "a method for simulated cerebral blood flow perfusion parametric imaging based on 18F-FDG." Panorama centers have participated in domestic and international top academic conferences multiple times, published multiple SCI articles, and have been selected for the world's most influential nuclear medicine and molecular imaging conference (SNMMI) for three consecutive years, with a total of 16 articles accepted. The Shanghai Xuhui, Hangzhou, and Guangzhou centers have been rated as national high-tech enterprises, with steadily increasing research investment and output. Panorama aims for group-based and chain-based development. Currently, Shanghai Xuhui and Hongkou, Beijing, Hangzhou, Guangzhou, Chongqing, Tianjin, Chengdu, Xuzhou, and Nanjing are in operation. Company website: *